Corporate Banner
Satellite Banner
Next Gen Sequencing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

OpGen Announces Formation of Public Health Consortium

Published: Friday, May 18, 2012
Last Updated: Friday, May 18, 2012
Bookmark and Share
Consortium to evaluate whole genome mapping for improved genetic analysis of disease outbreaks.

OpGen, Inc. announced the formation of a public health consortium to evaluate OpGen's Whole Genome Mapping technology as an enhanced method for strain typing microorganisms that cause disease outbreaks. The consortium is comprised of the Association of Public Health Laboratories (APHL), the Centers for Disease Control and Prevention (CDC), the University of Maryland Institute for Genome Sciences, and 11 state public health laboratories from across the United States.

The rise in disease outbreaks due to food borne illnesses and hospital acquired infections poses an ongoing threat to public health. Public health officials and healthcare organizations need access to improved first responder technologies to rapidly identify disease causing agents in order to effectively control and contain outbreaks and treat patients. Today's genotyping technologies, such as PFGE, are limited in the type of information they provide for microbial strain typing. OpGen's Whole Genome Mapping technology provides a rapid, comprehensive structural analysis of microbial genomes that, combined with sequencing, provides a new genetic analysis workflow that more accurately detects important genetic elements associated with virulence and drug resistance. The Whole Genome Map data can be used to guide sequencing of these targeted regions to enable more accurate understanding and response management at an early stage in outbreaks. The initial results from the consortium study will be presented on May 20th at the APHL annual meeting in Seattle, WA.

"We are extremely pleased to be working with our consortium partners to evaluate Whole Genome Mapping as an enhanced genetic analysis technology for confirmation and management of disease outbreaks," said Douglas White, chief executive officer of OpGen. "The level of accuracy and discrimination that is achieved by combining Whole Genome Mapping and next generation sequencing can enable a new paradigm for outbreak management."

The purpose of the consortium is to demonstrate the capabilities of Whole Genome Mapping as a more effective genomics analysis technology for outbreak analysis. "Public Health Laboratories operate as a first line of defense to protect the public against diseases and other health hazards, and as such we need to be using cutting-edge technologies to identify, address and protect the public from health risks," said Scott Becker, APHL executive director. "We are pleased to be part of this new consortium that brings together leaders in the public health field to collaborate on the use of new genomic analysis technologies to better identify and manage disease outbreaks."


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

OpGen Assists 100K Genome Project
OpGen, Inc. has entered into a scientific and technical partnership with UC Davis in cooperation with the 100K Genome Project to create high resolution microbial genetic maps.
Thursday, December 20, 2012
OpGen Announces Strategic Collaboration with IQT
The collaboration is focused on developing a new high-throughput sequence and genome mapping pipeline for microbial genome analysis.
Tuesday, May 01, 2012
OpGen's Whole Genome Mapping System Features at International Plant & Animal Genome XX Conference
The company announced today that the company's new Whole Genome Mapping and Genome Builder(TM) software was featured in a poster session at the International Plant & Animal Genome XX Conference, January 14-18, 2012 in San Diego.
Tuesday, January 17, 2012
OpGen Strengthens Management Team to Accelerate Commercialization Strategy
Whole genome analysis company appoints new CIO and names key executive positions.
Thursday, December 22, 2011
Scientific News
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
Rescuing Genetic Material from Formaldehyde Treated Tissue Samples
Formaldehyde is excellent for preserving cellular structures, but it makes it difficult to pull genetic information from tissue samples. Eric Kool and colleagues have developed a catalyst that saves RNA, which could lead to better patient outcomes.
DNA Damage Seen in Patients Undergoing CT Scanning
Along with the burgeoning use of advanced medical imaging tests over the past decade have come rising public health concerns about possible links between low-dose radiation and cancer.
Web App Helps Researchers Explore Cancer Genetics
Brown University computer scientists have developed a new interactive tool to help researchers and clinicians explore the genetic underpinnings of cancer.
New Research Advances Genetic Studies in Wildlife Conservation
‘Next-gen’ DNA sequencing of non-invasively collected hair expands field of conservation genetics.
Gene Testing Now Allows Precision Medicine for Thoracic Aneurysms
Researchers at the Aortic Institute at Yale have tested the genomes of more than 100 patients with thoracic aortic aneurysms, a potentially lethal condition, and provided genetically personalized care.
OGT’s Popular ESHG Workshop Free to View Online
Learn about the next generation of microarrays in one of the best attended workshops of the conference.
Discordant NIPT Test Results May Reflect Presence of Maternal Cancer
Results published in Journal of the American Medical Association.
Sperm RNA Test May Improve Evaluation of Male Infertility
To help resolve uncertainty—and guide prospective parents to the right fertility treatments—scientists propose the use of a new kind of fertility test. It involves examining sperm RNA by means of next-generation sequencing.
How the Mammoth Got its Wool
Evolutionary change in a gene reconstructed in the lab from the woolly mammoth was part of a suite of adaptations that allowed the mammoth to survive in harsh arctic environments, according to new research.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!